4.7 Article

The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome

Journal

FERTILITY AND STERILITY
Volume 94, Issue 4, Pages 1392-1398

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2009.07.1662

Keywords

Ovarian hyperstimulation syndrome (OHSS); abdominal compartment syndrome (ACS); intraabdominal pressure (IAP); intraabdominal hypertension (IAH); paracentesis

Funding

  1. Reproductive Biology and Medicine Branch, NICHD, NIH

Ask authors/readers for more resources

Objective: To compare and contrast the pathophysiology of ovarian hyperstimualtion syndrome (OHSS) with known syndromes of increased intraabdominal pressure (IAP), and to explore the relationship of increased IAP with symptom severity in OHSS. Design: Literature review. Main Outcome Measure(s): Correlation of OHSS symptoms with IAP; effects of paracentesis on IAP in patients with OHSS. Setting: Academic Research Institution. Intervention(s): None. Result(s): OHSS involves a rapid accumulation of volume (from 1.5-17 liters) in the peritoneal cavity that can lead to organ dysfunction, including respiratory impairment and oliguria. In published reports of 20 moderate-to-severe OHSS patients in whom IAP was measured, IAP was found to be elevated to a pathologic range. The increased IAP indicates that OHSS may be considered a compartment syndrome and meets criteria for abdominal compartment syndrome in advanced cases. For this reason, management of OHSS should include reduction of pressure by paracentesis to avoid morbidity and syndrome progression. In addition, measurement of IAP may help to classify the stage of OHSS. Conclusion(s): IAP was found to be elevated in the few cases of OHSS in which it was measured, substantiating the conclusion that OHSS may be considered a compartment syndrome. An understanding of the pathophysiology of increased intrabdominal pressure is useful in the management of OHSS. (Fertil Steril (R) 2010;94:1392-8. (C) 2010 by American Society for Reproductive Medicine.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Obstetrics & Gynecology

Genes involved in recurrent oocyte maturation arrest: What do we know?

James H. Segars, Maya Diab

FERTILITY AND STERILITY (2021)

Article Obstetrics & Gynecology

Conception by fertility treatment and offspring deoxyribonucleic acid methylation

Edwina H. Yeung, Pauline Mendola, Rajeshwari Sundaram, Xuehuo Zeng, Weihua Guan, Michael Y. Tsai, Sonia L. Robinson, Judy E. Stern, Akhgar Ghassabian, David Lawrence, Thomas G. O'Connor, James Segars, Robert E. Gore-Langton, Erin M. Bell

Summary: The study found that assisted reproductive technologies (ART) were associated with differences in DNA methylation levels at birth compared to children conceived without fertility treatment, but only one difference at an imprinting region appeared to persist in childhood.

FERTILITY AND STERILITY (2021)

Editorial Material Obstetrics & Gynecology

Validation of a highly realistic embryo transfer simulator and trainer

James Segars, Michael A. Thomas

FERTILITY AND STERILITY (2021)

Editorial Material Obstetrics & Gynecology

Vitamin D deficiency and uterine fibroids: an opportunity for treatment or prevention?

Md Soriful Islam, Most Mauluda Akhtar, James H. Segars

FERTILITY AND STERILITY (2021)

Editorial Material Obstetrics & Gynecology

S1P and activin A induce fibrotic phenotype in uterine fibroids: a promising target for antifibrotic therapy

Md Soriful Islam, Most Mauluda Akhtar, James H. Segars

Summary: Activin A plays a role in inducing a fibrotic phenotype in uterine fibroid cells by increasing ECM protein expression through activation of Smad 2/3 and p38 MAPK signaling pathways.

FERTILITY AND STERILITY (2021)

Article Obstetrics & Gynecology

A Phase I Clinical Trial to Assess Safety and Tolerability of Injectable Collagenase in Women with Symptomatic Uterine Fibroids

Bhuchitra Singh, Holly Sims, Irene Trueheart, Khara Simpson, Karen C. Wang, Kristin Patzkowsky, Thomas Wegman, Jean-Marie Soma, Rosina Dixon, Friederike Jayes, Kristin Voegltine, Gayane Yenokyan, Szu-Chi Su, Phyllis Leppert, James H. Segars

Summary: The study aimed to evaluate the safety and tolerability of collagenase injection directly into uterine fibroids. The results showed no significant adverse events following collagenase injection, and a reduction in collagen content by 39% and density by 21% in treated samples. Subjects reported a decrease in fibroid-related pain post-injection, supporting further clinical investigation of collagenase as a minimally invasive treatment for uterine fibroids.

REPRODUCTIVE SCIENCES (2021)

Article Multidisciplinary Sciences

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients

Nicholas W. Bateman, Christopher M. Tarney, Tamara Abulez, Anthony R. Soltis, Ming Zhou, Kelly Conrads, Tracy Litzi, Julie Oliver, Brian Hood, Paul Driggers, Coralie Viollet, Clifton Dalgard, Matthew Wilkerson, William Catherino, Chad A. Hamilton, Kathleen M. Darcy, Yovanni Casablanca, Ayman Al-Hendy, James Segars, Thomas P. Conrads, G. Larry Maxwell

Summary: Pathogenic mutations in fumarate hydratase (FH) drive hereditary leiomyomatosis and renal cell cancer (HLRCC) and increase the risk of developing uterine leiomyomas (ULMs). An integrated proteogenomic analysis of ULMs from HLRCC and non-syndromic patients identified a significantly higher protein:transcript correlation in HLRCC, along with co-altered proteins and transcripts related to oxidative stress response and cellular metabolism signaling. The study also confirmed and defined novel proteogenomic alterations in uterine leiomyoma tissues collected from HLRCC patients, emphasizing conserved molecular alterations correlating with inactivation of the FH tumor suppressor gene.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry

Nicholas W. Bateman, Christopher M. Tarney, Tamara S. Abulez, Brian L. Hood, Kelly A. Conrads, Ming Zhou, Anthony R. Soltis, Pang-Ning Teng, Amanda Jackson, Chunqiao Tian, Clifton L. Dalgard, Matthew D. Wilkerson, Michael D. Kessler, Zachary Goecker, Jeremy Loffredo, Craig D. Shriver, Hai Hu, Michele Cote, Glendon J. Parker, James Segars, Ayman Al-Hendy, John Risinger, Neil T. Phippen, Yovanni Casablanca, Kathleen M. Darcy, G. Larry Maxwell, Thomas P. Conrads, Timothy D. O'Connor

Summary: Characterization of ancestry-linked peptide variants in disease-relevant patient tissues is important for understanding the relationship between patient ancestry and disease pathogenesis. The study identifies peptide ancestry informative markers (pAIMs) to determine ancestry proportions and their correlation with patient race and genotype. The findings contribute to the understanding of the impact of ancestry on the human proteome and its relevance to uterine neoplasms.

ISCIENCE (2022)

Review Obstetrics & Gynecology

A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment

Abigail Combs, Bhuchitra Singh, Elisabeth Nylander, Md Soriful Islam, Ha Vi Nguyen, Elissa Parra, Ameerah Bello, James Segars

Summary: Vitamin D has emerged as a potential therapy for uterine fibroids based on experimental and clinical evidence. It has been found to decrease proliferation and Wnt/beta-catenin signaling in fibroid cells, and studies have shown its effectiveness in prevention and treatment of fibroids.

REPRODUCTIVE SCIENCES (2023)

Article Medicine, General & Internal

Pre-IVF treatment with a GnRH antagonist in women with endometriosis (PREGNANT): study protocol for a prospective, double-blind, placebo-controlled trial

Hugh Taylor, Howard J. Li, Sandra Carson, Valerie Flores, Lubna Pal, Jared Robbins, Nanette F. Santoro, James H. Segars, David Seifer, Hao Huang, Steven Young, Heping Zhang

Summary: This is a prospective study on the efficacy of GnRH antagonist pretreatment for women with endometriosis undergoing IVF. The study aims to recruit 814 patients who will be randomly assigned to receive either GnRH antagonist or placebo treatment for 8 weeks before undergoing IVF. The primary outcome is live birth, and secondary outcomes include oocyte number, fertilisation rate, embryo morphology, implantation rates, and endometriosis-related obstetrical outcomes.

BMJ OPEN (2022)

Article Obstetrics & Gynecology

Anatomic nomenclature and 3-dimensional regional model of the human ovary: call for a new paradigm

Kathleen E. O'Neill, Jacqueline Y. Maher, Monica M. Laronda, Francesca E. Duncan, Richard D. LeDuc, Marla E. Lujan, Kutluk H. Oktay, Alison M. Pouch, James H. Segars, Elizabeth L. Tsui, Mary B. Zelinski, Lisa M. Halvorson, Veronica Gomez-Lobo

Summary: This article introduces the conceptualization process and outcomes of an effort to standardize ovarian nomenclature and define the organ's features. The goal was to develop a spatially defined and semantically consistent terminology of the ovary to support collaborative, team science-based endeavors aimed at generating reference atlases of the human ovary. The new systems of nomenclature and mapping will better reflect the ovary's heterogeneous composition and function, support the standardization of tissue collection, facilitate functional analyses, and enable clinical and research collaborations.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Review Obstetrics & Gynecology

A Systematic Review of Minimally Invasive Approaches to Uterine Fibroid Treatment for Improving Quality of Life and Fibroid-Associated Symptoms

Joshua M. Morris, Angela Liang, Katarina Fleckenstein, Bhuchitra Singh, James Segars

Summary: This systematic review analyzed the effectiveness of minimally invasive approaches to treat fibroids and compared their impact on quality of life and symptoms. The results showed that radiofrequency ablation and ultrasound-guided sclerotherapy significantly improved quality of life, while uterine artery embolization and ultrasound-guided high-intensity frequency ultrasound had similar effects as surgical interventions. Minimally invasive approaches were effective alternatives to surgery for improving quality of life and fibroid-associated symptoms.

REPRODUCTIVE SCIENCES (2023)

Article Obstetrics & Gynecology

AKAP13 Enhances CREB1 Activation by FSH in Granulosa Cells

Kamaria C. Cayton Vaught, Dana Hazimeh, Ashlie Sewdass Carter, Kate Devine, Jacqueline Y. Maher, Marcy Maguire, Elizabeth A. McGee, Paul H. Driggers, James H. Segars

Summary: This study found that AKAP13 may function as a scaffolding protein in follicle-stimulating hormone (FSH) signal transduction by interacting with CREB, leading to phosphorylation of CREB.

REPRODUCTIVE SCIENCES (2023)

Article Obstetrics & Gynecology

The Utility and Impact of the Painful Periods Screening Tool (PPST) to Improve Healthcare Delivery for People with Symptoms of Pelvic Pain

Bhuchitra Singh, Julia Berry, Michelle Volovsky, Yanqing Xu, Ahmed M. Soliman, Carol B. Thompson, James H. Segars

Summary: The objective of this study was to evaluate the utility and impact of the Painful Periods Screening Tool (PPST) to improve healthcare delivery for people with symptoms of pelvic pain. The results showed that most participants reported severe pain during menstruation, and using the PPST helped them discuss their symptoms more easily with healthcare providers.

REPRODUCTIVE SCIENCES (2023)

Article Nutrition & Dietetics

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women

Hiba Siblini, Ayman Al-Hendy, James Segars, Frank Gonzalez, Hugh S. Taylor, Bhuchitra Singh, Ainna Flaminia, Valerie A. Flores, Gregory M. Christman, Hao Huang, Jeremy J. Johnson, Heping Zhang

Summary: This is an abstract of preliminary results from a clinical study on the use of EGCG for treating unexplained infertility associated with uterine fibroids. The study found that a daily dose of 800 mg of EGCG alone or in combination with clomiphene citrate or letrozole (for 5 days) is well-tolerated and not associated with liver toxicity or folate deficiency in reproductive-aged women.

NUTRIENTS (2023)

No Data Available